Amgen vs Boeing: Founders, CEOs and History
Amgen was founded in 1980 by George B. Rathmann, William K. Bowes Jr. and is led by Robert A. Bradway. Boeing was founded in 1916 by William E. Boeing, George Conrad Westervelt and is led by Kelly Ortberg.
Company facts
Founders
Amgen
George B. Rathmann
Amgen, originally incorporated as Applied Molecular Genetics, was founded in 1980 not by a single scientist, but by a calculated syndicate of venture capitalists and academics trying to commercialize the brand-new science of recombinant DNA.
William K. Bowes Jr.
William K. Bowes Jr. Was the venture capital strategist whose vision catalyzed Amgen's formation.
Boeing
William E. Boeing
The Boeing Company was founded in 1916 by William E. Boeing, a wealthy timber merchant, and George Conrad Westervelt, an US Navy engineer.
George Conrad Westervelt
George Conrad Westervelt occupies an unusual position in aviation history: a co-founder of what became the world's largest aerospace company who departed before the company was officially incorporated and whose subsequent contributions to aviation, while disti…
CEOs and their tenures
Amgen
- George B. Rathmann1980–1988
Chief Executive Officer
George Rathmann, a physical chemist who had run research and development at Abbott Laboratories, was named Amgen's first chief executive in 1980 and worked from a small trailer so that laboratory space could go to scientists.
Source - Gordon M. Binder1988–2000
Chief Executive Officer
Gordon Binder joined Amgen as chief financial officer in 1982 and led its June 1983 initial public offering.
Source - Kevin W. Sharer2000–2012
Chief Executive Officer
Kevin Sharer joined Amgen in 1992 as president and chief operating officer and became chairman and chief executive in 2000.
Source - Robert A. Bradway2012–present
Chairman and Chief Executive Officer
Robert Bradway became chief executive on May 23, 2012, succeeding Kevin Sharer as the fourth CEO in Amgen's history, and added the chairmanship at the start of 2013.
Source
Boeing
- William McPherson Allen1945–1968
Chief Executive Officer
As CEO for 16 years, he transitioned Boeing from a purely military bomber manufacturer into the undisputed global leader in commercial jet aviation, launching the 707, 727, 737, and 747.
Source - Thornton Wilson1969–1986
Chief Executive Officer
He saved the company from imminent bankruptcy during the catastrophic 'Boeing Bust' of 1969-1971 by ruthlessly cutting the workforce from 100,000 to 38,000 (the infamous 'Turn Out the Lights' era).
Source - Frank Shrontz1986–1996
Chief Executive Officer
As CEO through the late 1980s and 1990s, he pushed the company toward massive lean manufacturing initiatives and initiated the highly controversial merger with McDonnell Douglas.
Source - Philip M. Condit1996–2003
Chief Executive Officer
An engineer who led the 777 program, became CEO in 1996, completed the McDonnell Douglas merger in 1997 and moved headquarters from Seattle to Chicago in 2001. He resigned in December 2003 amid the tanker procurement scandal.
Source - Harry Stonecipher2003–2005
Chief Executive Officer
The former McDonnell Douglas CEO returned from retirement in December 2003 after Phil Condit resigned over the Air Force tanker-lease scandal. The board forced him out in March 2005 over a relationship with a female executive that broke company policy.
Source - James McNerney2005–2015
Chief Executive Officer
A former 3M chief executive hired in July 2005. He oversaw the 787 Dreamliner's delayed entry into service in 2011, launched the 737 MAX (2011) and 777X (2013), and pushed suppliers and labor hard on cost.
Source - James A. Bell2005–2005
Chief Executive Officer
He strictly enforced capital discipline during the 2008 financial crisis, ensuring Boeing retained the massive liquidity required to fund its commercial and defense pipelines.
Source - Dennis Muilenburg2015–2019
Chief Executive Officer
A Boeing engineer who became CEO in July 2015 and chairman in 2016. He led the company through the Lion Air (2018) and Ethiopian Airlines (2019) 737 MAX crashes and the worldwide grounding, and was fired in December 2019.
Source - Dave Calhoun2020–2024
Chief Executive Officer
A Boeing director and former GE executive who took over in January 2020 after Dennis Muilenburg was fired.
Source - Kelly Ortberg2024–present
President and Chief Executive Officer
Ortberg became Boeing's president and CEO on August 8, 2024, recruited from outside after more than 35 years in aerospace, including running Rockwell Collins as CEO from 2013 through its sale to United Technologies (later RTX).
Source
Timeline: Amgen and Boeing side by side
1916Boeing
Pacific Aero Products Company Incorporated
William Boeing incorporates Pacific Aero Products Co. on July 15, 1916 in Seattle, a month after the B&W seaplane he built with George Conrad Westervelt first flew from Lake Union on June 15.
1917Boeing
Renamed The Boeing Airplane Company; First Military Contract
The company is renamed The Boeing Airplane Company in April 1917 following co-founder George Westervelt's return to active Navy duty, and secures its first meaningful military contract when the U.S. Navy orders the improved Model C floatplane.
1927Boeing
Boeing Air Transport Wins San Francisco-Chicago Airmail Route
Boeing forms Boeing Air Transport and wins the U.S. Post Office airmail contract for the San Francisco to Chicago route, the most commercially valuable domestic airmail route, initiating Boeing's involvement in commercial aviation beyond manufacturing.
1933Boeing
Boeing 247 Introduced as the First Modern Airliner
Boeing introduces the Model 247, widely recognized as the world's first modern commercial airliner, featuring all-metal construction, retractable landing gear, a cantilevered wing, and variable-pitch propellers.
1954Boeing
Dash 80 Jet Prototype First Flies
The 367-80, or Dash 80, first flies on July 15, 1954, the company's 38th anniversary. Funded with about $16 million of Boeing's own money, it leads to the KC-135 tanker for the Air Force and the 707 airliner, which enters service with Pan Am in 1958.
1969Boeing
Boeing 747 Jumbo Jet Makes First Flight
The 747, the first wide-body jetliner, first flies on February 9, 1969 and enters service with Pan Am in January 1970.
1980Amgen
Applied Molecular Genetics is incorporated
Applied Molecular Genetics (AMGen) was incorporated on April 8, 1980 in Thousand Oaks, California, as the idea of venture capitalist William K. Bowes Jr. and a group of scientific collaborators.
1983Amgen
Nasdaq listing and the erythropoietin clone
Amgen completed its initial public offering on June 17, 1983, raising nearly US$40 million under chief financial officer Gordon Binder, and formally shortened its name to Amgen.
1984Amgen
Kirin-Amgen joint venture formed
Amgen and Kirin Brewery Company of Japan formed Kirin-Amgen in 1984 as a joint venture for the worldwide commercialization of erythropoietin.
1985Amgen
G-CSF cloned, leading to Neupogen
While Fu-Kuen Lin's team worked on erythropoietin, researcher Larry Souza and his group cloned and expressed human granulocyte colony-stimulating factor in 1985.
1989Amgen
FDA approves Epogen
The FDA approved Epogen (epoetin alfa) on June 1, 1989 for anemia in patients with chronic kidney failure on dialysis. It was the first commercial recombinant human erythropoietin. Epogen's U.S.
1991Amgen
Neupogen approved, giving Amgen a second franchise
The FDA approved Neupogen (filgrastim) in February 1991. By stimulating white blood cell production it reduced the risk of infection in cancer patients with chemotherapy-induced neutropenia.
1991Amgen
Amgen wins the erythropoietin patent fight
On March 6, 1991 the U.S. Court of Appeals for the Federal Circuit upheld the Kirin-Amgen erythropoietin patent and ruled against Genetics Institute in Amgen v. Chugai Pharmaceutical and Genetics Institute.
1994Boeing
Boeing 777 First Flight
The Boeing 777, the world's largest twin-engine commercial aircraft and the first airliner designed entirely using computer-aided design tools without physical mock-ups, makes its inaugural flight on June 12, 1994.
1997Boeing
Boeing Merges with McDonnell Douglas
Boeing completes its $13.3 billion acquisition of McDonnell Douglas, creating a single dominant American aerospace and defense company and ending more than two decades of three-way commercial aircraft competition.
2001Amgen
FDA approves Aranesp, the longer-acting EPO
Aranesp (darbepoetin alfa), an erythropoietin analogue with modified glycosylation and a longer half-life, was approved in 2001. Less frequent dosing than Epogen improved convenience and gave Amgen a newer, higher-priced product to migrate patients toward.
2002Amgen
US$16 billion Immunex acquisition brings Enbrel in-house
Amgen completed its acquisition of Immunex Corporation on July 16, 2002, the largest biotechnology deal to that point at about US$16 billion in stock and cash.
2009Boeing
Boeing 787 Dreamliner First Flight
The Boeing 787 Dreamliner, the first commercial aircraft built primarily from carbon-fiber composite materials, makes its first flight on December 15, 2009 more than two years behind its original 2007 schedule following extensive supply chain difficulties with…
2010Amgen
Prolia and XGEVA create the bone health franchise
The FDA approved Prolia (denosumab) for postmenopausal osteoporosis in June 2010 and XGEVA, the same molecule at a higher dose, for prevention of skeletal-related events in cancer patients in November 2010.
2019Amgen
US$13.4 billion purchase of Otezla from Celgene
Amgen agreed in August 2019 to buy worldwide rights to Otezla (apremilast) from Celgene for US$13.4 billion in cash, or about US$11.2 billion net of the present value of US$2.2 billion of anticipated future cash tax benefits, and closed on November 21, 2019.
2019Boeing
737 MAX Grounded Worldwide Following Two Fatal Crashes
After the Lion Air Flight 610 crash in October 2018 and the Ethiopian Airlines Flight 302 crash in March 2019, which killed 346 people, regulators ground the 737 MAX worldwide.
2020Amgen
Amgen joins the Dow Jones Industrial Average
Amgen replaced Pfizer in the Dow Jones Industrial Average on August 31, 2020, becoming one of the thirty components in the index. Inclusion recognized the scale Amgen had reached and added passive demand from Dow-tracking funds.
2022Boeing
Boeing Relocates Corporate Headquarters to Arlington, Virginia
Boeing formally moves its corporate headquarters from Chicago, Illinois, to Arlington, Virginia, placing its senior executive team adjacent to the Pentagon and within close proximity to Congress and the regulatory agencies that govern both its defense and comm…
2023Amgen
US$27.8 billion Horizon Therapeutics acquisition closes
Amgen completed the acquisition of Horizon Therapeutics plc on October 6, 2023 for US$116.50 per share in cash, an equity value of about US$27.8 billion, after settling FTC litigation with a behavioral consent decree.
2024Amgen
Imdelltra becomes the first T-cell engager for small cell lung cancer
The FDA granted accelerated approval to tarlatamab, sold as Imdelltra, on May 16, 2024 for extensive stage small cell lung cancer that has progressed on or after platinum-based chemotherapy.
2024Boeing
Door-Plug Blowout, Machinists Strike, and Leadership Transition
Alaska Airlines Flight 1282 experiences a door-plug blowout at 16,000 feet on January 5, triggering a FAA production cap on 737 MAX and a congressional investigation into Boeing's quality management.
2025Amgen
VESALIUS-CV extends the Repatha case to primary prevention
In November 2025 Amgen reported Phase 3 VESALIUS-CV results in more than 12,000 patients with atherosclerosis or diabetes but no prior heart attack or stroke.
2025Boeing
F-47 Win, Strike in St. Louis, Spirit Buyback and a Return to Profit
The Air Force selects Boeing's F-47 as its sixth-generation fighter in March. Boeing sells Jeppesen and other digital units to Thoma Bravo for $10.55 billion, the FAA raises the 737 cap to 42 a month in October, a 102-day strike at St.
2026Amgen
Medicare price setting reaches Enbrel and Otezla
Enbrel's negotiated Medicare price under the Inflation Reduction Act took effect on January 1, 2026, after it was named in the first round of ten drugs selected for negotiation.
2026Boeing
737-7 Certified, F/A-XX Win and a 737-10 Setback
Backlog reaches a record $715 billion at June 30. The FAA certifies the 737-7 on August 3, then on September 28 holds 737-10 certification over a flight-management software issue. On September 29 the Navy selects Boeing to build the F/A-XX fighter.
Acquisitions
Amgen
- Horizon Therapeutics plc2023$27.8B
- ChemoCentryx, Inc.2022$3.7B
- Five Prime Therapeutics2021$1.9B
- Celgene Otezla Business2019$13.4B
- Onyx Pharmaceuticals, Inc.2013$10.4B
- DeCODE Genetics2012$415M
Boeing
- Spirit AeroSystems2025$4.7B
- Aurora Flight Sciences2017Undisclosed
- Aviall2006$1.7B
- Jeppesen Sanderson2000$1.5B
- Hughes Electronics (space and communications business)2000$3.8B
- McDonnell Douglas1997$13.3B
Questions about Amgen vs Boeing
Who is the CEO of Amgen Inc. and The Boeing Company?
Amgen Inc. is led by Robert A. Bradway and The Boeing Company is led by Kelly Ortberg. Both serve as the top executive responsible for the company's strategy, operations, and financial performance.
When was Amgen Inc. founded vs The Boeing Company?
The Boeing Company was founded in 1916 — 64 years before Amgen Inc., which was founded in 1980. The Boeing Company's longer operating history gives it a deeper track record but also potentially more institutional inertia compared to the younger Amgen Inc..
How many employees does Amgen Inc. have compared to The Boeing Company?
Amgen Inc. employs approximately 31,500 people, while The Boeing Company employs approximately 182,000. The Boeing Company has the larger workforce at 182,000 employees, compared to Amgen Inc.'s 31,500. A higher headcount does not necessarily imply greater efficiency — it often reflects differences in business model (e.g., manufacturing vs. software).
Where are Amgen Inc. and The Boeing Company headquartered?
Both Amgen Inc. and The Boeing Company are headquartered in United States, meaning they operate under the same primary regulatory and tax environment.
Who founded Amgen Inc. and The Boeing Company?
Amgen Inc. was founded by George B. Rathmann, William K. Bowes Jr.. The Boeing Company was founded by William E. Boeing, George Conrad Westervelt.
Which company has a longer operating history — Amgen Inc. or The Boeing Company?
The Boeing Company has been operating for approximately 110 years, making it the more established of the two companies. Amgen Inc. has been in operation for around 46 years. A longer operating history often signals greater institutional resilience and brand recognition, though it can also mean slower adaptation to new market conditions.
Figures come from each company's filings and the sources linked beside them. Amounts reported in another currency are shown in US dollars at an approximate rate and marked with ~. Back to the Amgen vs Boeing overview